{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T12:08:04Z","timestamp":1776082084318,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.contraception.2003.10.002","type":"journal-article","created":{"date-parts":[[2004,2,12]],"date-time":"2004-02-12T10:15:01Z","timestamp":1076580901000},"page":"179-187","source":"Crossref","is-referenced-by-count":42,"title":["A 3-year double-blind, randomized, controlled study on the influence of two oral contraceptives containing either 20 \u03bcg or 30 \u03bcg ethinylestradiol in combination with levonorgestrel on bone mineral density"],"prefix":"10.1016","volume":"69","author":[{"given":"J.","family":"Endrikat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Mih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"D\u00fcsterberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Land","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Gerlinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Felsenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2003.10.002_BIB1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/09513599609041268","article-title":"A three-year clinical investigation into efficacy, cycle control and tolerability of a new low-dose monophasic oral contraceptive containing gestodene","volume":"10","author":"D\u00fcsterberg","year":"1996","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.contraception.2003.10.002_BIB2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0010-7824(99)00097-9","article-title":"Comparison of efficacy, cycle control and tolerability of two low-dose oral contraceptives in a multicenter clinical study","volume":"60","author":"Endrikat","year":"1999","journal-title":"Contraception"},{"issue":"Suppl","key":"10.1016\/j.contraception.2003.10.002_BIB3","first-page":"19","article-title":"German trial of an oral contraceptive containing 0.150 mg desogestrel plus 0.020 mg ethinylestadiol","volume":"44","author":"Nevinny-Stickel","year":"1988","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2003.10.002_BIB4","unstructured":"Teichmann A, Corbin A. Clinical experience with a monophasic oral contraceptive containing 150 \u03bcg levonorgestrel and 30 \u03bcg ethinylestradiol: efficacy, tolerance and metabolic interactions. Levonorgestrel, Thieme 1998:81\u201391"},{"key":"10.1016\/j.contraception.2003.10.002_BIB5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0010-7824(97)00157-1","article-title":"A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low dose oral contraceptive containing 20 \u03bcg ethinyl estradiol and 100 \u03bcg levonorgestrel over six treatment cycles","volume":"56","author":"Bannemerschult","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2003.10.002_BIB6","doi-asserted-by":"crossref","unstructured":"Hite RC, Bannemerschult R, Fox-Kuchenbecker, Turck R, Brill K. Large observational trial of a new low-dose oral contraceptive containing 20 \u03bcg ethinylestradiol and 100 \u03bcg levonorgestrel (Miranova\u00ae) in Germany. Eur J Contracept Reprod Health Care 1999;4:7\u201313","DOI":"10.3109\/13625189909043474"},{"key":"10.1016\/j.contraception.2003.10.002_BIB7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0010-7824(01)00221-9","article-title":"Multicenter, comparative study of cycle control, efficacy and tolerability of two low-dose oral contraceptives containing 20 \u03bcg ethinylestradiol\/100 \u03bcg levonorgestrel and 20 \u03bcg ethinylestradiol\/500 \u03bcg norethisterone","volume":"64","author":"Endrikat","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2003.10.002_BIB8","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0010-7824(93)90134-S","article-title":"Bone metabolism in young women taking a monophasic pill containing 20 \u03bcg ethinylestradiol","volume":"48","author":"Mais","year":"1993","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2003.10.002_BIB9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0010-7824(93)90040-E","article-title":"Contraception in older women","volume":"47","author":"Volpe","year":"1993","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2003.10.002_BIB10","unstructured":"Audran M, Delchambre J, Giraud H, Simon Y, Rohmer V. Effect of two new oral contraceptives on bone. Osteoporosis Proceedings Hong-Kong 1993;248:70"},{"key":"10.1016\/j.contraception.2003.10.002_BIB11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0010-7824(03)00025-8","article-title":"Effects of low-dose and ultra-low-dose combined oral contraceptives use on bone turnover and bone mineral density in young fertile women","volume":"67","author":"Nappi","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2003.10.002_BIB12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0010-7824(95)00036-A","article-title":"Bone mass and long-term monophasic oral contraceptive treatment in young women","volume":"51","author":"Polatti","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2003.10.002_BIB13","first-page":"75","article-title":"Reference values for trabecular and cortical vertebral bone density in single and dual-energy quantitative computed tomography","volume":"9","author":"Kalender","year":"1989","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.contraception.2003.10.002_BIB14","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/clinchem\/41.11.1560","article-title":"Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum","volume":"41","author":"Gomez","year":"1995","journal-title":"Clin Chem"},{"key":"10.1016\/j.contraception.2003.10.002_BIB15","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1210\/jc.77.4.1046","article-title":"Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease","volume":"77","author":"Garnero","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2003.10.002_BIB16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0009-8981(90)90050-3","article-title":"The preparation of monoclonal antibodies which react preferentially with human bone alkaline phosphatase and not liver alkaline phosphatase","volume":"186","author":"Hill","year":"1989","journal-title":"Clin Chem Acta"},{"issue":"Suppl 1","key":"10.1016\/j.contraception.2003.10.002_BIB17","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1007\/BF01623429","article-title":"Peak bone mass","volume":"4","author":"Bonjour","year":"1994","journal-title":"Osteoporosis Int"},{"key":"10.1016\/j.contraception.2003.10.002_BIB18","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s001980070099","article-title":"Longitudinal evaluation of perimenopausal femoral bone loss","volume":"11","author":"Gambacciani","year":"2000","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.contraception.2003.10.002_BIB19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0378-5122(94)90062-0","article-title":"Hormone replacement therapy in perimenopausal women with a low dose oral contraceptive preparation","volume":"19","author":"Gambacciani","year":"1994","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2003.10.002_BIB20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0029-7844(99)00493-7","article-title":"A randomized trial of oral contraceptive and hormone replacement therapy on bone mineral density and coronary heart disease risk factors in postmenopausal women","volume":"95","author":"Taechakraichana","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2003.10.002_BIB21","first-page":"12","article-title":"Effect of combined oral contraceptives on bone mineral density in pre- and postmenopausal women","volume":"11","author":"Sultana","year":"2002","journal-title":"Mymensingh Med J"},{"key":"10.1016\/j.contraception.2003.10.002_BIB22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF01623231","article-title":"The effect of previous oral contraceptive use on bone mineral density in perimenopausal women","volume":"4","author":"Tuppurainen","year":"1994","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.contraception.2003.10.002_BIB23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3109\/13625189709167466","article-title":"Biochemical aspects of hormonal contraception","volume":"2","author":"Volpe","year":"1997","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2003.10.002_BIB24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0022-3476(96)70148-8","article-title":"A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depot-Provera), levonorgestrel (Norplant), or oral contraceptives","volume":"129","author":"Cromer","year":"1996","journal-title":"J Pediatr"},{"key":"10.1016\/j.contraception.2003.10.002_BIB25","unstructured":"Drake A, Armstrong D, McDevitt E, Phull A, Shakir K. Bone mineral density and menstrual status in U.S. Naval Academy female midshipman. Program Abstr Endocr Soc Annu Meet 1996:P3\u2013799"},{"key":"10.1016\/j.contraception.2003.10.002_BIB26","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0002-9378(97)70396-X","article-title":"Bone mineral changes in young women with hypothalamic amenorrhea treated with oral contraceptives, medroxyprogesterone, or placebo over 12 months","volume":"176","author":"Hergenr\u00f6der","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2003.10.002_BIB27","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1001\/jama.268.17.2403","article-title":"Bone gain in young adult women","volume":"268","author":"Recker","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2003.10.002_BIB28","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0015-0282(00)00719-6","article-title":"Oral contraceptive use by teenage women does not affect peak bone mass","volume":"74","author":"Lloyd","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2003.10.002_BIB29","first-page":"107","article-title":"Serum alkaline phosphatase and bone mineral density","volume":"11","author":"Sultana","year":"2002","journal-title":"Mymensingh Med J"},{"key":"10.1016\/j.contraception.2003.10.002_BIB30","first-page":"237","article-title":"Biochemical markers of bone metabolism\u2014update 1999. Part I","volume":"45","author":"Seibel","year":"1999","journal-title":"Clin Lab"},{"key":"10.1016\/j.contraception.2003.10.002_BIB31","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1359\/jbmr.1997.12.7.1083","article-title":"Relationship of bone turnover to bone density and fractures","volume":"12","author":"Melton","year":"1997","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.contraception.2003.10.002_BIB32","doi-asserted-by":"crossref","first-page":"17S","DOI":"10.1097\/00007632-199712151-00004","article-title":"Bone biomarkers as tools in osteoporosis management","volume":"22","author":"Eyre","year":"1997","journal-title":"Spine"},{"key":"10.1016\/j.contraception.2003.10.002_BIB33","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0002-9343(97)00137-X","article-title":"Biochemical markers in the assessment of bone disease","volume":"103","author":"Bikle","year":"1997","journal-title":"Am J Med"},{"key":"10.1016\/j.contraception.2003.10.002_BIB34","first-page":"20","article-title":"Automated evaluation of CT images in the diagnosis of osteoporosis","volume":"57","author":"Kalender","year":"1989","journal-title":"Electromedia"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782403002683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782403002683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T18:57:20Z","timestamp":1585594640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782403002683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0010782403002683"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2003.10.002","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}